SARS-CoV-2 Mpro-IN-9

Modify Date: 2025-08-26 18:00:11

SARS-CoV-2 Mpro-IN-9 Structure
SARS-CoV-2 Mpro-IN-9 structure
Common Name SARS-CoV-2 Mpro-IN-9
CAS Number 2754370-99-3 Molecular Weight 346.34
Density N/A Boiling Point N/A
Molecular Formula C20H14N2O4 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of SARS-CoV-2 Mpro-IN-9


SARS-CoV-2 Mpro-IN-9 (compound c7) is a nonpeptidic, noncovalent SARS-CoV-2 Mpro inhibitor (IC50=0.085 μM), with improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties. SARS-CoV-2 Mpro-IN-9 inhibits viral replication (EC50=1.10 μM) in SARS-CoV-2-infected Vero E6 cells, while exhibits low cytotoxic effects (CC50>50 μM)[1].

 Names

Name SARS-CoV-2 Mpro-IN-9

 SARS-CoV-2 Mpro-IN-9 Biological Activity

Description SARS-CoV-2 Mpro-IN-9 (compound c7) is a nonpeptidic, noncovalent SARS-CoV-2 Mpro inhibitor (IC50=0.085 μM), with improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties. SARS-CoV-2 Mpro-IN-9 inhibits viral replication (EC50=1.10 μM) in SARS-CoV-2-infected Vero E6 cells, while exhibits low cytotoxic effects (CC50>50 μM)[1].
Related Catalog
Target

IC50: 0.085 μM (SARS-CoV-2), EC50: 1.10 μM (viral replication)[1]

References

[1]. Zhang K, et al. Discovery of quinazolin-4-one-based non-covalent inhibitors targeting the severe acute respiratory syndrome coronavirus 2 main protease (SARS-CoV-2 Mpro). Eur J Med Chem. 2023 Sep 5;257:115487.  

 Chemical & Physical Properties

Molecular Formula C20H14N2O4
Molecular Weight 346.34
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.